Pharmacodynamic data and coagulation biomarkers in person with hemophilia A with inhibitors: results from the HAVEN 1 emicizumab phase 3 study - Adamkewicz, J I; Schmitt, C; Asikanius, E (2017)
; Berlin, Germany